p21-activated kinase 1: PAK’ed with potential
Metrics: PDF 3486 views | HTML 4667 views | ?
1 Department of Translational Oncology, Genentech, Inc., South San Francisco, CA 94080, USA
2 The Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford OX3 9DS, UK
3 Department of Bioinformatics, Genentech, Inc., South San Francisco, CA 94080, USA
4 Department of Pathology, Genentech, Inc., South San Francisco, CA 94080, USA
* These authors contributed equally to this work.
Keywords: PAK1, apoptosis, squamous, lung cancer, breast cancer
Received: May 3, 2011; Accepted: June 2, 2011; Published: June 7, 2011;
Klaus P. Hoeflich, e-mail:
The p21-activated kinases (PAKs) are central players in growth factor signaling networks and morphogenetic processes that control proliferation, cell polarity, invasion and actin cytoskeleton organization. This raises the possibility that interfering with PAK activity may produce significant anti-tumor activity. In this perspective, we summarize recent data concerning the contribution of the PAK family member, PAK1, in growth factor signaling and tumorigenesis. We further discuss mechanisms by which inhibition of PAK1 can arrest tumor growth and promote cell apoptosis, and the types of cancers in which PAK1 inhibition may hold promise.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.